Medicine & Life Sciences
Transplant Recipients
100%
Cytomegalovirus
85%
HIV
85%
Infections
80%
Coronavirus
67%
Transplants
59%
Adenoviridae
48%
Cytomegalovirus Infections
48%
Liver Transplantation
44%
T-Lymphocytes
41%
Therapeutics
40%
HIV-1
39%
Antiviral Agents
37%
Vaccines
37%
SARS Virus
37%
HIV Infections
35%
Virus Diseases
35%
Viruses
33%
Organ Transplantation
31%
Endocarditis
28%
Equipment and Supplies
27%
Apoptosis
25%
Hepacivirus
25%
Mortality
23%
Vaccination
23%
Human Herpesvirus 6
23%
Opportunistic Infections
22%
Transplantation
22%
Serogroup
21%
Community-Based Participatory Research
21%
Pharmaceutical Preparations
20%
Severe Acute Respiratory Syndrome
20%
Tuberculosis
20%
Pandemics
18%
Bacteremia
17%
Kidney
17%
Retroviridae Infections
17%
Allografts
16%
Immunization
16%
Ganciclovir
16%
Genes
16%
Refugees
16%
Tissue Donors
15%
Protease Inhibitors
15%
Human Influenza
15%
Immunocompromised Host
15%
Monoclonal Antibodies
15%
Joints
14%
Proteins
14%
Propionic Acidemia
14%
Cell Death
14%
Mycoses
14%
Genetic Therapy
14%
Chronic Hepatitis C
14%
Epidemiology
13%
Population
13%
Hospitalization
13%
Confidence Intervals
12%
Viremia
12%
DNA
12%
Liver
12%
Hematopoietic Stem Cells
12%
Incidence
12%
Communicable Diseases
12%
Lung
11%
Valganciclovir
11%
HIV Protease Inhibitors
11%
Safety
11%
Ritonavir
11%
Cohort Studies
11%
Viral Load
10%
In Vitro Techniques
10%
Adenovirus Vaccines
10%
Anti-Bacterial Agents
10%
Fever
10%
Human Adenoviruses
10%
Cryptococcosis
10%
Polymerase Chain Reaction
10%
Caspase 8
10%
Hematopoietic Stem Cell Transplantation
10%
Acquired Immunodeficiency Syndrome
9%
Morbidity
9%
Herpesviridae Infections
9%
AIC246
9%
Reverse Transcriptase Inhibitors
9%
Heart
9%
Heme Oxygenase-1
9%
Invasive Fungal Infections
9%
Randomized Controlled Trials
9%
Health
9%
Peptides
9%
lens epithelium-derived growth factor
8%
Ribavirin
8%
Anti-Retroviral Agents
8%
Nelfinavir
8%
Human Herpesvirus 7
8%
Highly Active Antiretroviral Therapy
8%
Staphylococcus aureus
8%
Feline Immunodeficiency Virus
8%
GS-5734
8%